Innovative Medical Technology

Neurotron, Incorporated

   Innovative Medical Technology

                 Established 1981

Neurometer® Pharmacology & Toxicology Applications

 Patient Care

 Research

 Press Releases

 

 Products

 

 Exhibitions

 

 Clinical Apps

 

 F.A.Q.

 

 Downloads

 

 Contact

 The utility and sensitivity of the CPT evaluation has resulted in it being utilized by the pharmaceutical and other industries for the past 23 years as a safety device to screen for neurotoxic side effects or exposure effects or to monitor for neuro-protective effects in the clinical evaluation of new pharmaceutical agents for FDA approval.  See citations of pharmacology and toxicology publications utilizing Neurometer technology.


 

top of page      Previous page     Home

 

 

The entire contents of this web site are Copyright 1996-2010, Neurotron, Incorporated

Est. 1981, Baltimore, MD, USA.  All rights reserved, worldwide

rev 10/16/09